Multi-regional whole-exome sequencing of 10 HCC patients undergoing curative resection (4-9 regions analyzed) coupled with cell line derivation of these regions shows regional drug sensitivity. Spatial distribution of known cancer drivers within the same patients could justify heterogeneous response to targeted therapies.

(Gao Q et al. – Gastroenterology, January 2017)

Read more